FinnCap reissued their corporate rating on shares of Cambridge Cognition Holdings PLC (LON:COG) in a research report released on Tuesday morning. The firm currently has a GBX 130 ($1.68) price objective on the stock.
Shares of Cambridge Cognition Holdings PLC (LON COG) opened at 146.50 on Tuesday. The stock’s market capitalization is GBX 29.76 million. The stock has a 50 day moving average price of GBX 127.50 and a 200 day moving average price of GBX 110.67. Cambridge Cognition Holdings PLC has a 12 month low of GBX 60.21 and a 12 month high of GBX 165.00.
WARNING: This piece was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.chaffeybreeze.com/2017/09/15/cambridge-cognition-holdings-plcs-cog-corporate-rating-reiterated-at-finncap.html.
Cambridge Cognition Holdings PLC Company Profile
Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company’s segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials.
Receive News & Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related companies with MarketBeat.com's FREE daily email newsletter.